October 1, 1996 - September 30, 1997
Armed Forces Institute of Pathology (FDA-224-82-5000). To collaborate in a pilot project intended to assess the feasibility/usefulness of a heart valve study group.
Biocon, Incorporated (FDA-223-96-6050). Housing and care for experimental animals.
Environmental Protection Agency (FDA-224-97-6010). Development of animal models for reproductive and developmental toxicity risk assessments.
Mentor Technologies (FDA-223-94-6015). Evaluation of the safety of clinical and cosmetic uv devices, used for or by HIV-infected individuals: experimental and clinical studies.
National Academy of Sciences (FDA-223-93-6007). To establish a CDRH/FDA research associateship program through the NRC of the NAS to further the purposes of FDA in research.
National Institutes of Standards and Technology (FDA-224-93-6015). Secondary calibration - National Voluntary Laboratory Accreditation Program.
National Institutes of Environmental Health Sciences (FDA-224-94-6013). Effects of extremely low frequency (ELF) fields on selected human cell lines.
National Research Council (FDA-223-93-6007). To establish a CDRH/FDA research associateship program through the National Research Council to further the purposes of FDA in research.
Office of Emergency Preparedness (FDA-224-95-6011). Support services for modifying emergency response equipment.
Office of Naval Research (FDA-224-92-6007). Evaluation of single crystal sapphire fibers for medical applications.
Sachs-Freeman, Inc. (FDA-223-96-6051). Characterize reference equipment used to determine the dosimetry of mammography x-ray beams.
U.S. Department of Energy (FDA-224-88-6064). Establish and conduct a research fellowshiip program.